Pubblicazioni

Gabert J, Beillard E, Van Der Velden VH, Bi W, Grimwade D, Pallisgaard N, Barbany G, Cazzaniga G, Cayuela JM, Cave H, Pane F, Aerts JL, De Micheli D, Thirion X, Pradel V, Gonzalez M, Viehmann S, Malec M, Saglio G, Van Dongen JJ. Standardization and quality control studies of ‘real-time’ quantitative reverse transcriptase polymerase […]

Eckert C, Scrideli CA, Taube T, Songia S, Wellmann S, Manenti M, Seeger K, Biondi A, Cazzaniga G. Comparison between TaqMan and LightCycler technologies for quantification of minimal residual disease by using immunoglobulin and T-cell receptor genes consensus probes. Leukemia. 2003;17:2517-24

Cazzaniga G, Gaipa G, Rossi V and Biondi A. Minimal residual disease as a surrogate marker for risk assignment to ALL patients. Rev Clin Exp Hematol. 2003;7:292-323

Scrideli CA, Cazzaniga G, Fazio G, Pirola L, Callegaro A, Bassan R, Rambaldi A, Nigro LL, Basso G, Masera G, Biondi A. Gene expression profile unravels significant differences between childhood and adult Ph+ acute lymphoblastic leukemia. Leukemia. 2003;17:2234-2237

Tosi S, Hughes J, Scherer SW, Nakabayashi K, Harbott J, Haas OA, Cazzaniga G, Biondi A, Kempski H, Kearney L. Heterogeneity of the 7q36 breakpoints in the t(7;12) involving ETV6 in infant leukemia. Genes Chromosomes Cancer. 2003;38:191-200

Gunby RH, Cazzaniga G, Tassi E, Le Coutre P, Pogliani E, Specchia G, Biondi A, Gambacorti-Passerini C. Sensitivity to imatinib but low frequency of the TEL/PDGFRb fusion protein in chronic myelomonocytic leukemia. Haematologica. 2003;88:408-15

Germano G, del Giudice L, Palatron S, Giarin E, Cazzaniga G, Biondi A, Basso G. Clonality profile in relapsed precursor-B-ALL children by GeneScan and sequencing analyses. Consequences on minimal residual disease monitoring.Leukemia. 2003 Aug;17(8):1573-82

Bertoni F, Conconi A, Capella C, Motta T, Giardini R, Ponzoni M, Pedrinis E, Novero D, Rinaldi P, Cazzaniga G, Biondi A, Wotherspoon A, Hancock BW, Smith P, Souhami R, Cotter FE, Cavalli F, Zucca E. Molecular follow-up in gastric mucosa-associated lymphoid tissue lymphomas: early analysis of the LY03 cooperative trial. Blood. 2002 Apr 1;99(7):2541-4

Bellavia D, Campese AF, Checquolo S, Balestri A, Biondi A, Cazzaniga G, Lendahl U, Fehling HJ, Hayday AC, Frati L, von Boehmer H, Gulino A, Screpanti I. Combined expression of pTalpha and Notch3 in T cell leukemia identifies the requirement of preTCR for leukemogenesis. Proc Natl Acad Sci U S A. 2002 Mar 19;99(6):3788-93

Longoni D., D’Amico G., Gaipa G., Vulcano M., Niemeyer C.M., Allavena P. and Biondi A. Committment of pathological monocytic cells from JMML patients to spontaneously differentiate into dendritic cells. 2002. The Hematol. Journal. 3:302-306

Manganini M, Serafini M, Bambacioni F, Casati C, Erba E, Follenzi A, Naldini L, Bernasconi S, Gaipa G, Rambaldi A, Biondi A, Golay J, Introna M. A human immunodeficiency virus type 1 pol gene-derived sequence (cPPT/CTS) increases the efficiency of transduction of human nondividing monocytes and T lymphocytes by lentiviral vectors. Hum Gene Ther. 2002 […]

Balduzzi A, Perseghin P, Dassi M, Bonanomi S, Rovelli A, Gaipa G, Biondi A, Uderzo C. Peripheral blood stem cell collection in children with acute leukemia: effectiveness of the ‘DIAVE’ mobilizing regimen. Bone Marrow Transplant. 2002 Oct;30(7):413-6. PubMed PMID: 12368951

Todisco E, Gaipa G, Biagi E, Bonamino M, Gramigna R, Introna M, Biondi A. CD40 ligand-stimulated B cell precursor leukemic cells elicit interferon-gamma production by autologous bone marrow T cells in childhood acute lymphoblastic leukemia. Leukemia. 2002 Oct;16(10):2046-54. PubMed PMID: 12357356

Gaipa G, Coustan-Smith E, Todisco E, Maglia O, Biondi A, Campana D. Characterization of CD34+, CD13+, CD33- cells, a rare subset of immature human hematopoietic cells. Haematologica. 2002 Apr;87(4):347-56. PubMed PMID: 11940478

Longoni D, D’Amico G, Gaipa G, Bernasconi S, Vulcano M, Onnis P, Niemeyer CM, Allavena P, Biondi A. Commitment of juvenile myelo-monocytic (JMML) leukemic cells to spontaneously differentiate into dendritic cells. Hematol J. 2002;3(6):302-10. PubMed PMID: 12522453

Manganini M., Serafini M., Bambacioni F., Casati C., Erba E., Follenzi A., Naldini L., Bernasconi S., Gaipa G., Rambaldi A., Biondi A., Golay J., Introna M. (2002) “A Hiv-1 pol gene derived sequenze increases the efficiency of transduction of human non dividing monocytes and T lymphocytes by lentiviral vectors”. Human Gene Therapy, 13(15): 1793-1807.

Cazzaniga G, d’Aniello E, Corral L, Biondi A. Results of minimal residual disease (MRD) evaluation and MRD-based treatment stratification in childhood ALL. Best Pract Res Clin Haematol. 2002;15:623-38

Cazzaniga G, Lanciotti M, Rossi V, Di Martino D, Arico M, Valsecchi MG, Basso G, Masera G, Micalizzi C, Biondi A. Prospective molecular monitoring of BCR/ABL transcript in children with Ph+ acute lymphoblastic leukaemia unravels differences in treatment response. Br J Haematol. 2002 Nov;119(2):445-53

Carlotti E, Pettenella F, Amaru R, Slater S, Lister TA, Barbui T, Basso G, Cazzaniga G, Rambaldi A, Biondi A. Molecular characterization of a new recombination of the SIL/TAL-1 locus in a child with T-cell acute lymphoblastic leukaemia. Br J Haematol. 2002 Sep;118(4):1011-8

Cazzaniga G, Rossi V, Biondi A. Monitoring minimal residual disease using chromosomal translocations in childhood ALL. Best Pract Res Clin Haematol. 2002 Mar;15(1):21-35